Former Interim President and Chief Executive Officer, and Director · LENZ Therapeutics, Inc. (LENZ)

Kimberlee Drapkin

A named executive officer of LENZ Therapeutics in every fiscal year CompBrief holds from FY2023 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,097,345

Salary $163,541Stock awards $0Bonus $200,000

FY2023: $271,669

4th of 4 named executive officers at Lenz Therapeutics by FY2024 total.

4 named officers on file for LENZ Therapeutics, FY2024

Kimberlee Drapkin’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how LENZ Therapeutics’s whole pay program stands against its peers

  • LENZ Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on LENZ→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2025 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Kimberlee Drapkin’s full pay file as a PDF — free

More than this page: up to 10 years of Kimberlee’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Kimberlee Drapkin compensation by year

LENZ Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as LENZ Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024
Salary$200,521$163,541
Bonus$0$200,000
Stock awards$0$0
Option awards$71,148$333,804
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$0$400,000
Total$271,669$1,097,345

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: LENZ Therapeutics, Inc. DEF 14A filed April 28, 2025, accession 0001193125-25-100630, and prior-year filings. Open the filing on EDGAR.

How this page was built: the LENZ Therapeutics, Inc. filed document, accession 0001193125-25-100630. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2025.

$272K
$1.1M
FY23
FY24
SalaryBonusOption awardsAll other

Insider transactions since the last proxy

2 Form 4 lines since the FY2024 proxy (filed April 28, 2025)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-06-15Grant or award derivative—22,100$0.0022,100
2025-06-11Grant or award derivative—13,500$0.0013,500

The 2 most recent of 2 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

LENZ Therapeutics’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Evert SchimmelpenninkPresident and Chief Executive Officer$6,983,510
Daniel ChevallardChief Financial Officer$3,063,051
Marc OdrichChief Medical Officer$2,039,143
Kimberlee Drapkin · this pageFormer Interim President and Chief Executive Officer, and Director$1,097,345

Board service

LENZ Therapeutics board · FY2024–FY2025
Director compensation in US dollars, as LENZ Therapeutics reports it. Most recent year first; a dash means the company reported no figure in that column.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$51,000$0$304,081$0$355,081
FY2024———$0—

Each year as the company reported it in LENZ Therapeutics's director compensation table. Totals are the company's own disclosed totals.

How this board is paid

Company policy: LENZ Therapeutics pays directors a $40,000 cash retainer. As stated in LENZ Therapeutics's FY2025 proxy.

Committees

Audit · Compensation · Nominating/Governance

The full LENZ Therapeutics compensation record

free company brief

This page is one person within LENZ Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are LENZ Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Kimberlee Drapkin's compensation dossier · One-time report. No refunds.